Diabetes mellitus and glucose as predictors of mortality in primary coronary percutaneous intervention

Renato Budzyn David1, Eduardo Dytz Almeida1, Larissa Vargas Cruz1

  • 1Instituto de Cardiologia, Fundação Universitária de Cardiologia, Porto Alegre, RS, Brazil.

Insights

Admission blood glucose is a stronger predictor of 30-day mortality in ST-elevation myocardial infarction patients undergoing primary PCI than a diabetes mellitus diagnosis. This highlights the critical role of glycemic control in cardiovascular outcomes.

Area of Science:

  • Cardiology
  • Endocrinology
  • Public Health

Background:

  • Diabetes mellitus and admission blood glucose are known risk factors for mortality in ST-elevation myocardial infarction (STEMI) patients.
  • The independent and relative contributions of these factors to mortality remain debated.

Purpose of the Study:

  • To investigate the influence of diabetes mellitus and admission blood glucose on mortality in STEMI patients undergoing primary percutaneous coronary intervention (PCI).

Main Methods:

  • A prospective cohort study included 740 STEMI patients undergoing primary PCI.
  • Data collected included clinical, angiographic, and laboratory parameters.
  • Multivariate analysis adjusted for GRACE score variables, with 30-day follow-up.

Main Results:

  • Diabetes mellitus prevalence was 18%.
  • Univariate analysis showed both diabetes and admission glucose predicted 30-day mortality.
  • Multivariate analysis revealed admission blood glucose as an independent predictor (RR 1.05, CI 1.02-1.09, p≤0.01), while diabetes mellitus did not (RR 2.41, CI 0.76-7.59, p=0.13).

Conclusions:

  • Admission blood glucose is a more accurate and robust predictor of 30-day mortality in STEMI patients post-primary PCI than a prior diabetes diagnosis.
  • This finding underscores the significant role of inflammation and glycemic status in patient outcomes.
Abstract

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.8K
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
9
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.5K
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose...
2
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated...
5
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K